Found: 2
Select item for more details and to access through your institution.
Doublet or Triplet Antiemetic Prophylaxis for Nausea and Vomiting Induced by Trastuzumab Deruxtecan: an Open-Label, Randomized, and Multicenter Exploratory Phase 2 Study.
- Published in:
- Journal of Cancer, 2023, v. 14, n. 14, p. 2644, doi. 10.7150/jca.87169
- By:
- Publication type:
- Article
Neoadjuvant chemotherapy using nanoparticle albumin-bound paclitaxel plus trastuzumab and pertuzumab followed by epirubicin and cyclophosphamide for operable HER2-positive primary breast cancer: a multicenter phase II clinical trial (PerSeUS-BC04).
- Published in:
- Breast Cancer (13406868), 2023, v. 30, n. 2, p. 293, doi. 10.1007/s12282-022-01425-2
- By:
- Publication type:
- Article